Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer.

[1]  E. Perez,et al.  Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer , 2012, Cancer.

[2]  S. Edge,et al.  Impact of body mass index on clinical outcomes in triple‐negative breast cancer , 2011, Cancer.

[3]  R. Prentice,et al.  Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor–Positive Breast Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[4]  Charles M Perou,et al.  Molecular stratification of triple-negative breast cancers. , 2010, The oncologist.

[5]  C. Sweeney,et al.  Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[7]  A. Onitilo,et al.  Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival , 2009, Clinical Medicine & Research.

[8]  S. Narod,et al.  Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers , 2009, Breast Cancer Research and Treatment.

[9]  G. Hortobagyi,et al.  Prognostic Value of Body Mass Index in Locally Advanced Breast Cancer , 2008, Clinical Cancer Research.

[10]  K. Hess,et al.  Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Narod,et al.  Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence , 2007, Clinical Cancer Research.

[12]  C. Perou,et al.  The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes , 2007, Clinical Cancer Research.

[13]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[14]  G. Hortobagyi,et al.  Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Caldas,et al.  Molecular classification and molecular forecasting of breast cancer: ready for clinical application? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  P. Wingo,et al.  Body Mass and Mortality After Breast Cancer Diagnosis , 2005, Cancer Epidemiology Biomarkers & Prevention.

[17]  Graham A. Colditz,et al.  Physical activity and survival after breast cancer diagnosis , 2005 .

[18]  Therese Sørlie,et al.  Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. , 2004, European journal of cancer.

[19]  L. Goldstein,et al.  Prognostic and predictive factors in early-stage breast cancer. , 2004, The oncologist.

[20]  S. Cummings,et al.  Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. , 2003, Journal of the National Cancer Institute.

[21]  S. Edge,et al.  Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. , 2003, The Surgical clinics of North America.

[22]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[23]  M. Thun,et al.  Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women , 2002, Cancer Causes & Control.

[24]  Cathy J Bradley,et al.  Race, socioeconomic status, and breast cancer treatment and survival. , 2002, Journal of the National Cancer Institute.

[25]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Winer,et al.  Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[28]  A. Lethaby,et al.  Survival of women with node negative breast cancer in the Auckland region. , 1996, The New Zealand medical journal.

[29]  William H. Hartmann,et al.  The World Health Organization Histological Typing of Breast Tumors—Second Edition , 1982 .

[30]  Black Mm,et al.  Nuclear structure in cancer tissues. , 1957 .

[31]  M. Ewertz,et al.  Effect of obesity on prognosis after early-stage breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  K. Hess,et al.  DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer. , 2011, The oncologist.

[33]  S. Tretli,et al.  Pre-morbid body-mass-index in breast cancer: Reversed effect on survival in hormone receptor negative patients , 2005, Breast Cancer Research and Treatment.

[34]  I. Prpić-Križevac,et al.  Hyperinsulinemia and sex hormones in healthy premenopausal women: relative contribution of obesity, obesity type, and duration of obesity. , 1998, Metabolism: clinical and experimental.

[35]  L. Holmberg,et al.  Oral contraceptives and prognosis in breast cancer: effects of duration, latency, recency, age at first use and relation to parity and body mass index in young women with breast cancer. , 1994, European journal of cancer.

[36]  The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization. , 1982, American journal of clinical pathology.